These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 9364416

  • 1. Synthesis of several substituted phenylpiperazines behaving as mixed D2/5HT1A ligands.
    Dukić S, Kostić-Rajacić S, Dragović D, Soskić V, Joksimović J.
    J Pharm Pharmacol; 1997 Oct; 49(10):1036-41. PubMed ID: 9364416
    [Abstract] [Full Text] [Related]

  • 2. Structure-affinity relationship studies on D-2/5-HT1A receptor ligands. 4-(2-Heteroarylethyl)-1-arylpiperazines.
    Dukić S, Vujović M, Soskić V, Joksimović J.
    Arzneimittelforschung; 1997 Mar; 47(3):239-43. PubMed ID: 9105540
    [Abstract] [Full Text] [Related]

  • 3. New substituted 2-methylthiomethyl- and 2-methylsulphinylmethylenebenzimidazoles with D2/5-HT1A activity.
    Kostić-Rajacić S, Soskić V, Joksimović J.
    Pharmazie; 1998 Jul; 53(7):438-41. PubMed ID: 9699220
    [Abstract] [Full Text] [Related]

  • 4. Investigation of mixed D2/5-HT1A activity of N-heteroarylmethyl-N-phenylpiperazines, N-heteroarylethyl-N-phenylpiperazines and N-heteroarylpropyl-N-phenylpiperazines.
    Roglić G, Dukić-Stefanović S, Andrić D, Kostić-Rajacić S, Soskić V.
    Pharmazie; 2001 Oct; 56(10):803-7. PubMed ID: 11683128
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Introduction of a methyl group in alpha- or beta-position of 1-heteroarylethyl-4-phenylpiperazines affects their dopaminergic/serotonergic properties.
    Roglic G, Andric D, Kostic-Rajacic S, Dukic S, Soskic V.
    Arch Pharm (Weinheim); 2001 Dec; 334(12):375-80. PubMed ID: 11852532
    [Abstract] [Full Text] [Related]

  • 7. trans-4-[4-(Methoxyphenyl)cyclohexyl]-1-arylpiperazines: a new class of potent and selective 5-HT(1A) receptor ligands as conformationally constrained analogues of 4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]-1-arylpiperazines.
    Perrone R, Berardi F, Colabufo NA, Leopoldo M, Lacivita E, Tortorella V, Leonardi A, Poggesi E, Testa R.
    J Med Chem; 2001 Dec 06; 44(25):4431-42. PubMed ID: 11728188
    [Abstract] [Full Text] [Related]

  • 8. Bioisosteric approach in the design of new dopaminergic/serotonergic ligands.
    Soskić V, Joksimović J.
    Curr Med Chem; 1998 Dec 06; 5(6):493-512. PubMed ID: 9873112
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and dopaminergic properties of 3- and 4-substituted 1-[2-[5-(1H-benzimidazole-2-thione)]ethyl]piperidines and related compounds.
    Dukic S, Kostic-Rajacic S, Soskic V, Joksimovic J.
    Arch Pharm (Weinheim); 1997 Dec 06; 330(1-2):25-8. PubMed ID: 9112811
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and dopaminergic features of six novel 3-arylpiperidines.
    Kostic-Rajacic A, Soskic V, Joksimovic J.
    Boll Chim Farm; 1998 Nov 06; 137(10):417-21. PubMed ID: 10025971
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and pharmacological evaluation of 1-[(1,2-diphenyl-1H-4-imidazolyl)methyl]-4-phenylpiperazines with clozapine-like mixed activities at dopamine D(2), serotonin, and GABA(A) receptors.
    Asproni B, Pau A, Bitti M, Melosu M, Cerri R, Dazzi L, Seu E, Maciocco E, Sanna E, Busonero F, Talani G, Pusceddu L, Altomare C, Trapani G, Biggio G.
    J Med Chem; 2002 Oct 10; 45(21):4655-68. PubMed ID: 12361392
    [Abstract] [Full Text] [Related]

  • 12. Synthesis and evaluation of N,N-di-n-propyl-5,6,7,8-tetrahydro-1 H-benz[f]benzimidazol-6-yl-amine and related congeners as dopaminergic ligands.
    Dragović D, Soskić V, Joksimović J.
    Pharmazie; 1995 Oct 10; 50(10):678-80. PubMed ID: 7501691
    [Abstract] [Full Text] [Related]

  • 13. Substituted phenoxyalkylpiperazines as dopamine D3 receptor ligands.
    Laszlovszky I, Acs T, Kiss B, Domány G.
    Pharmazie; 2001 Apr 10; 56(4):287-9. PubMed ID: 11338664
    [Abstract] [Full Text] [Related]

  • 14. Synthesis of N-n-propyl-N-(2-arylethyl)-5-(1H-benzimidazol-2-thione)-eth ylamines and related compounds as potential dopaminergic ligands.
    Soskic V, Dukić S, Dragović D, Joksimović J.
    Arzneimittelforschung; 1996 Aug 10; 46(8):741-6. PubMed ID: 9125270
    [Abstract] [Full Text] [Related]

  • 15. The effect of chronic treatment with a novel aryl-piperazine antipsychotic on monoamine receptors in rat brain.
    Shapiro LA, Offord SJ, Ordway GA.
    Brain Res; 1995 Apr 24; 677(2):250-6. PubMed ID: 7552250
    [Abstract] [Full Text] [Related]

  • 16. 5-HT1A-versus D2-receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazines.
    Kuipers W, Kruse CG, van Wijngaarden I, Standaar PJ, Tulp MT, Veldman N, Spek AL, IJzerman AP.
    J Med Chem; 1997 Jan 31; 40(3):300-12. PubMed ID: 9022796
    [Abstract] [Full Text] [Related]

  • 17. Novel 4-alkyl-1-arylpiperazines and 1,2,3,4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-HT1A/5-HT2A/D2 receptor activity.
    Paluchowska MH, Mokrosz MJ, Charakchieva-Minol S, Duszyńska B, Kozioł A, Wesołowska A, Stachowicz K, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2003 Jan 31; 55(4):543-52. PubMed ID: 14581712
    [Abstract] [Full Text] [Related]

  • 18. Mixed 5-HT1A/D-2 activity of a new model of arylpiperazines: 1-aryl-4-[3-(1,2-dihydronaphthalen-4-yl)-n-propyl]piperazines. 1. Synthesis and structure-activity relationships.
    Perrone R, Berardi F, Colabufo NA, Tortorella V, Fiorentini F, Olgiati V, Vanotti E, Govoni S.
    J Med Chem; 1994 Jan 07; 37(1):99-104. PubMed ID: 8289207
    [Abstract] [Full Text] [Related]

  • 19. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives.
    Berardi F, Colabufo NA, Giudice G, Perrone R, Tortorella V, Govoni S, Lucchi L.
    J Med Chem; 1996 Jan 05; 39(1):176-82. PubMed ID: 8568804
    [Abstract] [Full Text] [Related]

  • 20. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
    Gozlan H, Thibault S, Laporte AM, Lima L, Hamon M.
    Eur J Pharmacol; 1995 Jan 16; 288(2):173-86. PubMed ID: 7720779
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.